Greenstreet Yvonne (CIK 0001446125)

Latest company ownership

Shares held
407
Last filed at
Dec 1, 2025
Confidence Score
67.7
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 26, 2025 Dec 1, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 20.0 -1,121 -1.59% $499K
Nov 12, 2025 Nov 14, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 37.5 -25,650 -1.77% $11.6M
Oct 1, 2025 Oct 3, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +9,188 16.23% $4M
Aug 15, 2025 Aug 19, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +7,273 14.74% $3.2M
May 30, 2025 Jun 3, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 7.5 -50,937 -24.93% $15.5M
Mar 3, 2025 Mar 5, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 97.5 +14,088 16.58% $945.2K
Feb 27, 2025 Mar 3, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 40.0 -2,900 -3.30% $700.9K
Feb 13, 2025 Feb 18, 2025 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 90.0 +2,646 3.34% $309.5K
Nov 25, 2024 Nov 27, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 95.0 +5,439 7.37% $1.3M
Aug 20, 2024 Aug 22, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 15.0 -15,000 -16.88% $4.2M
Aug 1, 2024 Aug 2, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 15.0 -15,148 -17.02% $4.1M
Jul 11, 2024 Jul 12, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 23.8 -7,093 -8.76% $1.9M
Jun 24, 2024 Jun 26, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +8,652 11.97% $1.9M
Feb 27, 2024 Feb 29, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 40.0 -2,932 -5.70% $455.4K
Feb 15, 2024 Feb 20, 2024 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +9,923 27.86% $1M
Aug 3, 2023 Aug 7, 2023 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 97.5 +4,884 15.89% $754K
Apr 26, 2023 Apr 28, 2023 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +9,337 43.63% $1.5M
Aug 3, 2022 Aug 5, 2022 ALNYLAM PHARMACEUTICALS, INC. CEO Sell 100.0 +7,093 49.57% $1.2M
Dec 21, 2021 Dec 23, 2021 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +2,879 25.19% $479.7K
Aug 6, 2021 Aug 9, 2021 ALNYLAM PHARMACEUTICALS, INC. COO Sell 2.5 -53,064 -82.28% $10.6M
Apr 19, 2021 Apr 21, 2021 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +2,732 31.41% $310K
Feb 11, 2021 Feb 16, 2021 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +3,471 66.41% $303.4K
Jan 12, 2021 Jan 13, 2021 ALNYLAM PHARMACEUTICALS, INC. COO Sell 7.5 -3,125 -37.42% $503.1K
Jul 10, 2020 Jul 14, 2020 ALNYLAM PHARMACEUTICALS, INC. COO Sell 3.8 -46,639 -89.92% $7.5M
Jul 9, 2020 Jul 10, 2020 ALNYLAM PHARMACEUTICALS, INC. COO Sell 5.0 -11,236 -68.25% $1.8M
May 5, 2020 May 7, 2020 ALNYLAM PHARMACEUTICALS, INC. COO Sell 3.8 -57,811 -85.19% $8.6M
Apr 7, 2020 Apr 9, 2020 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +2,904 125.01% $263.5K
Feb 7, 2020 Feb 11, 2020 ALNYLAM PHARMACEUTICALS, INC. COO Sell 5.0 -16,142 -65.42% $2.1M
Dec 12, 2019 Dec 13, 2019 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +4,292 184.76% $386.9K
Nov 20, 2019 Nov 22, 2019 ALNYLAM PHARMACEUTICALS, INC. COO Sell 7.5 -8,404 -78.34% $882.4K
Aug 30, 2018 Sep 4, 2018 ALNYLAM PHARMACEUTICALS, INC. COO Sell 7.5 -2,500 -52.92% $300K
Aug 13, 2018 Aug 14, 2018 ALNYLAM PHARMACEUTICALS, INC. COO Sell 97.5 +4,491 1927.47% $280.5K
Mar 26, 2018 Mar 28, 2018 ALNYLAM PHARMACEUTICALS, INC. COO Sell 7.5 -6,988 -96.77% $986K